With the global psychedelic drugs market projected to grow at a compound annual growth rate of 12.36 per cent between 2021 and 2027 to a value of US$10.75 billion in 2027 and the world’s first psychedelic exchange-traded fund launched in Canada at the start of the year, should institutional investors be taking notice? Read: Is it […]